Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Phase 2 and Pilot Pharmacodynamic Trial Investigating the Effect of Salovum™ and SPC-flakes on Dihydropyrimidine Induced Gastrointestinal Toxicity and Tumour Perfusion in Colorectal Cancer

NCT05339230 is registered in ClinicalTrials.gov with Uppsala University Hospital as lead sponsor.

NCT NCT05339230
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05339230 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Phase 2 and Pilot Pharmacodynamic Trial Investigating the Effect of Salovum™ and SPC-flakes on Dihydropyrimidine Induced Gastrointestinal Toxicity and Tumour Perfusion in Colorectal Cancer
Lead sponsor
Uppsala University Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
December 15, 2020
Completion date
June 30, 2025
Enrollment
73 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dihydropyrimidine induced gastrointestinal toxicity in colorectal cancer